Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2020-01-20
Original market date: See footnote 1
2016-11-25
Product name:
APO-CICLESONIDE
DIN:
02417316
Product Monograph/Veterinary Labelling:
Date:
2017-07-27
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
APOTEX INC
150 Signet Drive
Toronto
Ontario
Canada
M9L 1T9
Class:
Human
Dosage form(s):
Spray, Metered Dose
Route(s) of administration:
Nasal
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
R01AD13 CICLESONIDE
Active ingredient group (AIG) number:See footnote5
0151669004
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CICLESONIDE | 50 MCG / ACT |